Can Conventional ECG Technology Capture Fetal Cardiac Activity?



Status:Recruiting
Healthy:No
Age Range:18 - 55
Updated:10/18/2018
Start Date:June 2, 2017
End Date:June 2019
Contact:Martin G Frasch, MD, PhD
Email:mfrasch@uw.edu
Phone:206-543-5892

Use our guide to learn which trials are right for you!

This is a feasibility study for a new application for capturing fetal cardiac activity. The
objective of this study is to determine if it is feasible to capture a fetal ECG signal using
a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR)
device.

The objective of this study is to determine if it is feasible to capture a fetal ECG signal
using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate
(FHR) device. To obtain the raw FHR data from this standard device we will use the currently
approved "fetal EEG" monitor. The important distinction is that "fetal EEG" monitor will not
be connected to fetal scalp electrode, but, rather, get the data from the regular, more
routinely used and non-invasive Doppler FHR monitor. We expect that we will be able to
validate our algorithm with our maternal and fetal ECG channels to derive the FHR.

We will attach a Holter ECG device (4 electrodes) and a standard Doppler FHR device to a
pregnant woman who is between 32 weeks gestation and full term. ECG leads will be placed in
four corners of the abdomen. The targeted length of the recording will be 30 minutes. The
subject will remain supine and resting while the device is recording. Additionally, the
recently approved fetal EEG monitor will be connected to the Doppler FHR device to allow us
to obtain a "digital copy" of the standard FHR recording. We will do that in order to have
the comparison during the offline processing of the abdominal ECG with regard to the location
of the fetal R peaks. This procedure will be done after the subject's routine antepartum
testing. No women in active labor will be recruited.

Inclusion Criteria:

- Singleton or twin pregnant women at 32 weeks gestation to full term after routine
antepartum testing.

Exclusion Criteria:
We found this trial at
1
site
Seattle, Washington 98104
(206) 543-2100
Principal Investigator: Martin Frasch, MD, PhD
Phone: 206-543-5892
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
?
mi
from
Seattle, WA
Click here to add this to my saved trials